# Nanobiotix S.A.: financial statements, quarterly

NBTX · Nasdaq · CIK 1760854 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nbtx.md) · [Financials](/companies/nbtx/financials.md) · [Filings](/companies/nbtx/filings.md) · [Insiders](/companies/nbtx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nbtx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [47.2](/filings/0001628280-21-006685.md) | [36.2](/filings/0001628280-22-008842.md) | [35.1](/filings/0001760854-23-000005.md) | [119](/filings/0001760854-24-000004.md) | [83.9](/filings/0001760854-25-000005.md) | [41.4](/filings/0001760854-26-000003.md) | [75.3](/filings/0001760854-26-000003.md) | [49.7](/filings/0001760854-26-000003.md) | [52.8](/filings/0001760854-26-000003.md) |
| Current assets | $m | not reported | [42.5](/filings/0001628280-21-006685.md) | [46.1](/filings/0001628280-21-006685.md) | [125](/filings/0001628280-22-008842.md) | [93.1](/filings/0001760854-23-000005.md) | [52.4](/filings/0001760854-24-000004.md) | [87.3](/filings/0001760854-25-000005.md) | [61.5](/filings/0001760854-26-000003.md) | [62.8](/filings/0001760854-26-000003.md) |
| Total assets | $m | not reported | [51.6](/filings/0001628280-21-006685.md) | [56.2](/filings/0001628280-21-006685.md) | [134](/filings/0001628280-22-008842.md) | [102](/filings/0001760854-23-000005.md) | [59.8](/filings/0001760854-24-000004.md) | [93.9](/filings/0001760854-25-000005.md) | [67.4](/filings/0001760854-26-000003.md) | [67.8](/filings/0001760854-26-000003.md) |
| Current liabilities | $m | not reported | [12.2](/filings/0001628280-21-006685.md) | [14.3](/filings/0001628280-21-006685.md) | [19.0](/filings/0001628280-22-008842.md) | [36.8](/filings/0001760854-23-000005.md) | [37.9](/filings/0001760854-24-000004.md) | [49.9](/filings/0001760854-25-000005.md) | [58.9](/filings/0001760854-26-000003.md) | [57.5](/filings/0001760854-26-000003.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | [95.7](/filings/0001760854-25-000005.md) | [133](/filings/0001760854-26-000003.md) | [152](/filings/0001760854-26-000003.md) |
| Shareholders' equity | $m | [43.9](/filings/0001628280-21-006685.md) | [14.2](/filings/0001628280-22-008842.md) | [(1.9)](/filings/0001760854-23-000005.md) | [70.5](/filings/0001760854-23-000005.md) | [26.8](/filings/0001760854-25-000005.md) | [(27.0)](/filings/0001760854-26-000003.md) | [(1.8)](/filings/0001760854-26-000003.md) | [(65.7)](/filings/0001760854-26-000003.md) | [(84.5)](/filings/0001760854-26-000003.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 48,410,068 at 2025-12-31, from the cover of the [20-F filed 2026-03-31](/filings/0001760854-26-000003.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.